Skip to main content

Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells

The Original Article was published on 07 March 2017

Retraction to: Cancer Cell Int (2017) 17:36 https://doi.org/10.1186/s12935-017-0407-9

The Editors-in-Chief have retracted this article [1]. Concerns were raised regarding a number of figures, specifically:

  • Figure 3a: the first and third panel for C33A appear to partially overlap.

  • Figure 3b: panel 2 for C33A appears to partially overlap with panel 2 for C33A in Figure 7b.

  • Figure 7a: panel 1 for HeLa appears to overlap with panel 3 for HeLa in Figure 7b.

  • Figure 7a: panel 3 for C33A appears to partially overlap with panels 4 and 4 for C33A in Figure 7b: panel 6 for HeLa appears to partially overlap with panel 5 for C33A.

The Editors-in-Chief therefore no longer have confidence in the reliability of the data reported in the article.

All authors agree to this retraction.

Reference

  1. 1.

    Hu Y, Xie H, Liu Y, Liu W, Liu M, Tang H. miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells. Cancer Cell Int. 2017;17:36. https://doi.org/10.1186/s12935-017-0407-9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hua Tang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hu, Y., Xie, H., Liu, Y. et al. Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells. Cancer Cell Int 21, 255 (2021). https://doi.org/10.1186/s12935-021-01958-0

Download citation